Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]-
Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]- Basic information
- Product Name:
- Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]-
- Synonyms:
-
- Ipragliflozin Impurity A
- Ipragliflozin-003
- Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]-
- Methyl 1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-alpha-D-glucopyranoside
- (2S,3R,4S,5S,6R)-2-(3-(benzo[b]thiophen-2-ylMethyl)-4-fluorophenyl)-6-(hydroxyMethyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triol
- Methyl 1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-α-D-glucopyranoside
- Ipragliflozin impurity A (C7)
- Methyl 1-C-[3-(1-benzothien-2-ylmethyl)-4-fluorophenyl]-alpha-glucopyranoside
- CAS:
- 1034305-23-1
- MF:
- C22H23FO6S
- MW:
- 434.48
- Mol File:
- 1034305-23-1.mol
Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]- Chemical Properties
- storage temp.
- 2-8°C(protect from light)
Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]- Usage And Synthesis
Application
Methyl 1-C-[3-(benzo[B]thiophene-2-ylmethyl)-4-fluorophenyl]-ALPHA-D-glucopyranoside can be used as an analytical standard and reference, mainly in laboratory research and development processes and chemical production processes.
Synthesis
67-56-1
1034305-17-3
32469-28-6
1034305-23-1
A tetrahydrofuran solution of 0.9 M n-butylmagnesium chloride (0.9 M, 7.3 mL) was slowly added to toluene (18.0 mL) at -16 °C. Subsequently, n-hexane solution of n-butyllithium (2.66 M, 4.9 mL) was added dropwise at -12 °C and stirred for 16 min in the range of -12 to -15 °C. 2-(5-bromo-2-fluorobenzyl)benzo[b]thiophene (Compound I, 2.000 g) was dissolved in toluene (10.0 mL) and added dropwise to the reaction system at -12 to -15 °C, the dropwise process lasted for 1 hour. Next, a toluene solution (10.0 mL) of (3S,4S,5R,6R)-3,4,5-tris((trimethylmethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one (Compound II, 3.197 g) was added dropwise to the reaction solution and stirred for 3 hours at -12 to -15 °C. Upon completion of the reaction, the mixture was poured into a methanol solution (10.0 mL) of methanesulfonic acid (3.0 mL) at 0 °C or lower, followed by stirring for 16 hours and 36 minutes at room temperature. The reaction mixture was quenched with an aqueous sodium carbonate solution of pH about 8. The organic layer was washed with saturated brine (10 mL, once), dried over anhydrous sodium sulfate, and extracted with ethyl acetate (50 mL, twice). After filtration, the solvent was removed by distillation under reduced pressure and the resulting residue was purified by silica gel column chromatography to afford the target product (2S,3R,4S,5S,6R)-2-(3-(benzo[b]thiophene-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5triol (2.336 g, 86.4% yield).
References
[1] Patent: TW2016/2128, 2016, A. Location in patent: Paragraph 0024; 0025
[2] Patent: EP2105442, 2009, A1. Location in patent: Page/Page column 14
Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]-Supplier
- Tel
- 0551-68779238 18056025720
- sales3@lcywhx.com
- Tel
- 18149758185
- sales-cpd@caerulumpharma.com
- Tel
- 18680818008/15802381793
- cqudgh@126.com
- Tel
- 021-24206007 13764915196
- sales@balmxy.com
- Tel
- 021-60345187 13671753212
- lzz841106@aliyun.com
Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]-(1034305-23-1)Related Product Information
- CPNQ
- Bromothymol Blue
- 2-Methylindole
- Trimethylamine
- Octadecyl methacrylate
- Vitamin B series
- (2S,3R,4S,5S,6R)-2-(3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)-4-chlorophenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy-2H-pyran-3,4,5-triol
- (2S,3R,4S,5S)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,6-bis(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
- Benzo[b]thiophene, 2-[(5-broMo-2-fluorophenyl)Methyl]-
- L-Proline compd. with (1S)-1,5-anhydro-1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-D-glucitol (1:1)
- Benzo[b]thiophene-2-Methanol, α-(5-broMo-2-fluorophenyl)-
- Ipragliflozin